LALPATHLAB

What Dr. Lal Path Labs promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 18 tracked 7 delivered 2 missed 9 open
  • Revenue Growth revised up said Q4 FY26 Promised: Early to mid-teens Q1 FY27: Revenue grew 19.1% YoY. Management now indicates a bias towards mid-teens growth for FY27, stating 'chances are we might be more towards mid-teens rather than early teens'.
  • Patient Volume Growth delivered said Q3 FY25 Promised: 7-8% (aspirational) Q4 FY26: Sample volume growth of 12.9% in Q4 and 10.4% for FY26.
  • New Lab Additions missed said Q4 FY25 Promised: 15-20 for FY26 Q4 FY26: Added 14 new labs in FY26.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 18 tracked commitments for Dr. Lal Path Labs — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens